Patents by Inventor Felicity Caris Kalinowski

Felicity Caris Kalinowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors
    Patent number: 9051551
    Abstract: The present invention relates to a method for sensitizing a disease cell expressing the epidermal growth factor receptor (EGFR) to a tyrosine kinase inhibitor selective or specific for EGFR and/or its signalling pathway, the method comprising contacting the cell with a miR-7 miRNA, a precursor or variant thereof, or a miRNA comprising a seed region comprising the sequence GGAAGA.
    Type: Grant
    Filed: November 24, 2010
    Date of Patent: June 9, 2015
    Assignee: The University of Western Australia
    Inventors: Peter Jeffery Leedman, Keith Michael Giles, Felicity Caris Kalinowski
  • METHODS AND COMPOSITIONS FOR INCREASING SENSITIVITY TO TYROSINE KINASE INHIBITORS
    Publication number: 20130116299
    Abstract: The present invention relates to a method for sensitizing a disease cell expressing the epidermal growth factor receptor (EGFR) to a tyrosine kinase inhibitor selective or specific for EGFR and/or its signalling pathway, the method comprising contacting the cell with a miR-7 miRNA, a precursor or variant thereof, or a miRNA comprising a seed region comprising the sequence GGAAGA.
    Type: Application
    Filed: November 24, 2010
    Publication date: May 9, 2013
    Inventors: Peter Jeffery Leedman, Keith Michael Giles, Felicity Caris Kalinowski
  • MODULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR LIGANDS
    Publication number: 20130090366
    Abstract: The present invention relates to a method for modulating the expression and/or activity of an epidermal growth factor receptor (EGFR) ligand in a cell or tissue, the method comprising contacting the cell or tissue with a miR-7 miRNA, a pre-cursor or variant thereof, a miRNA comprising a seed region comprising the sequence GGAAGA, or an antagonist of any such miRNA.
    Type: Application
    Filed: November 24, 2010
    Publication date: April 11, 2013
    Inventors: Peter Jeffery Leedman, Keith Michael Giles, Felicity Caris Kalinowski